Allele discrimination depends on sequence-specific recognition at the nucleotide position that differs between variants. A probe or primer can produce a signal when its sequence pairs appropriately with one allele but not the alternative. This selective pairing converts a one-base sequence difference into a measurable result, allowing the assay to separate possible genotypes.
Sequencing distinguishes alleles through nucleotide incorporation as the DNA sequence is read, whereas PCR or hybridization methods detect allele-specific amplification or binding signals. These approaches therefore use different forms of evidence: sequencing compares the resulting sequence information, while targeted assays infer the allele from whether a designed reaction or probe recognizes it.
A reference sequence provides the comparison point needed to identify whether a patient’s sequence contains a one-base difference. The result is not interpreted from an isolated signal alone; it is evaluated against the expected reference or against alternative allele-specific signals. This comparison supports consistent classification of sequence variation for later clinical or research analysis.
A typical workflow begins by examining the patient’s relevant DNA sequence or testing it with an allele-specific system. The selected approach may use PCR, hybridization probes, or DNA sequencing. Researchers then interpret amplification, probe-binding, or sequence-incorporation results to determine which allele is present and relate that finding to the question being studied.
In medicine, the approach can support genetic diagnosis, pharmacogenomics, risk assessment, and investigations of inherited traits. It is especially relevant when a genetic difference has been linked with disease susceptibility or treatment response. By identifying the patient’s allele, testing can contribute to decisions or analyses concerned with variation in clinical outcomes.
Individual testing connects a patient’s allele with inherited traits, disease susceptibility, or response to treatment. At the population level, comparing variants across groups helps researchers examine how genetic differences relate to clinical outcomes and inherited patterns. These complementary uses make SNP detection relevant both to personalized medicine and to broader studies of human variation.